Navigation Links
Effect on breast tumors of DNA alternations in 3 genes described

Cancer epidemiologists at the University at Buffalo have identified specific genes that are most likely to become cancer promoters when exposed to a process called DNA promoter hypermethylation.

Hypermethylation is a process that causes genes that promote normal cell growth to produce proteins that cause malignant behavior, or unregulated cell growth. Until now, data has been very limited regarding the mechanism and causes of hypermethylation, especially for hypermethylation in breast cancer. The purpose of the current study was to determine how DNA hypermethylation relates to other characteristics of breast tumors.

"It is well known that mutation in genes -- alterations in their sequence -- is one of the characteristics of tumors responsible for some of their disease properties," said Menghua Tao, Ph.D., research assistant professor of social and preventive medicine in the UB School of Public Health and Health Professions and first author on the study.

"In addition, it is now becoming clear that other changes in the DNA may also contribute to the development of cancer."

The researchers analyzed methylation status in three genes, known as E-cadherin, p16 and retinoic acid B2 receptor (RAR-B2), using tissue samples from 887 breast cancers. The samples were taken from women 35-79 years old who participated in the Western New York Exposures and Breast Cancer Study (WEB study). Extensive in-person interviews were used to collect information on potential breast-cancer risk factors and confounding factors.

Results of the research were presented at the American Association of Cancer Research meeting held in Los Angeles in April.

"We found that hypermethylation of E-cadherin, but not of the other genes, was more likely to occur in estrogen receptor (ER)-negative than in ER-positive tumors," said Tao. ER-positive tumors are those that express receptors for the hormone estrogen. Such tumors respond to treatments that
'"/>

Source:University at Buffalo


Page: 1 2

Related biology news :

1. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
2. Effective Cancer Treatments Follow The Clock
3. FDA Works To Speed The Advent Of New, More Effective Personalized Medicines
4. Fungus Effective Against Winged Termites
5. NCI Researchers Confirm the Effectiveness of Immunotherapy Approach to Treating Melanoma
6. Duke Experiments Boost Radiations Cancer-Killing Effects
7. Effective, safe anthrax vaccine can be grown in tobacco plants
8. Effective HIV control may depend on viral protein targeted by immune cells
9. Viral DNA sequence a possible trigger for breast cancer
10. Used in a new way, RNA interference permanently silences key breast cancer gene
11. Biomarkers isolated from saliva successfully predict oral and breast cancer

Post Your Comments:
(Date:11/20/2009)...possess an ingenious mechanism for preventing oxyg...his is the new finding of a team of biologists tha...esearch institute in Flanders, Belgium, connected ...made this discovery by modifying the DNA of the in... this model organism, they have uncovered the exis...
(Date:11/20/2009)...COPD), a respiratory disease commonly known as chr...g cause of death worldwide. 600 million people li...d any real treatment or cure, Grace Parraga of Rob...rn Ontario in London, Canada, is using various ima...se. , Parraga is a scientist in the Imaging ...
(Date:11/19/2009)...al with an unwieldy name: 4-hydroxybutyrate (4-HB)...te-rape drug. , Now, a team of Ohio and Michiga...-HB is metabolized by the body. "This is new and i...fessor and chair of biological sciences at Michiga...earch team. "It may provide new clues on how to c...
Breaking Biology News(10 mins):Biologists discover bacterial defense mechanism against aggressive oxygen 2Gaining a better picture of lung disease 2Researchers begin to decipher metabolism of sexual assault drug 2SHPS Receives Re Accreditation from URAC for Multiple Health Management Programs 48486 1SHPS Receives Re Accreditation from URAC for Multiple Health Management Programs 48486 2Studies Report More Harmful Effects From BPA 48481 1Studies Report More Harmful Effects From BPA 48481 2Studies Report More Harmful Effects From BPA 48481 3Preliminary report on antidepressants published 48477 1Preliminary report on antidepressants published 48477 2
...effects of nutrition on blood disease porphyria ,... have uncovered a molecular explanation for the ep... in porphyria, the disease believed to have afflic...d for the loss of the American colonies in the Rev... of porphyria, a rare genetic blood disease which ...
...ch of genetic material may turn off the immune sup...h a vaccine, said researchers at Baylor College of...,s issue of the journal Science, Dr. Rong-Fu Wang,...herapy and Department of Immunology, and his colle...tion of a special group of T cells to suppress imm...
...d researcher who is now a chief of an immunology l...H) has rocked the boat in the past few years for t...system. , NIH,s Polly Matzinger has developed the ...is more concerned with damage detected on the basi...duction of foreign invaders, such as viruses. If M...
Other Biology News:Attacks of King George III's madness linked to key metabolism molecule 2Attacks of King George III's madness linked to key metabolism molecule 3Improving the potential of cancer vaccines 2Researchers seek to discover what really happens when a virus enters the body 2Researchers seek to discover what really happens when a virus enters the body 3
(Date:11/19/2009)...FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), an...r to its shareholders, discussing the Company,s ac...ceuticals Holdings, Inc. (CHBP), an integrated bio...blic of China. The merger gives NeoStem a controll... Ltd., CHBP,s primary operating subsidiary and a p...
(Date:11/19/2009)... - Aegera Therapeutics Inc. announced today the do... study of AEG35156, a targeted antisense therapeut...indications. ,, The study, entitled "An Open-La...itor of Apoptosis (XIAP) Antisense AEG35156 Given ...bicin in AML Following Failure of a Single Standar...
(Date:11/19/2009)...ber 19 AFFiRiS AG will focus its,A...e at an unexpectedly early,stage of development: t...,Phase II clinical trial early in 2010. This decis...ion of two Phase I trials with the candidates,AD01...the first interim,analysis of the secondary endpoi...
(Date:11/18/2009)...ed postage stamp that can sniff out poisonous gase...As reported in the Sept. 13 issue of the journal ... the University of Illinois have developed an arti...ustrial chemicals (TICs) that is simple, fast and ... sensor array could be useful in detecting high ex...
Breaking Biology Technology:NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3
...ov. 7 At an Amgen (Nasdaq: AMGN ),meeting of abo...rk City,today, several members of its senior manag... which includes delivering on its pipeline -- incl...ing in-line products and continuing,to pursue oper...kbuster products and today we have five,blockbuste...
...gistry is an observational study undertaken to eva...ervation (egg freezing) techniques, ROCKLAND, Mas...iliate,of Merck KGaA of Darmstadt, Germany, announ...perience (HOPE) Registry surrounding next week,s 6...roductive Medicine (ASRM).,The HOPE Registry is th...
...Md., Nov. 7 Human Genome Sciences,Inc. (Nasdaq: ...e Deutsche,Bank Biotech Boston Confab will be webc... (Logo: http://www.newscom.com/cgi-bin/prnh/2008...s, senior management team will present,a corporate... Eastern Time., Investors interested in listening...
Other Biology Technology:Amgen Positioned to Deliver Attractive Growth Over Next Five Years 2Amgen Positioned to Deliver Attractive Growth Over Next Five Years 3Amgen Positioned to Deliver Attractive Growth Over Next Five Years 4Amgen Positioned to Deliver Attractive Growth Over Next Five Years 5Amgen Positioned to Deliver Attractive Growth Over Next Five Years 6EMD Serono Launches Landmark Patient Registry for Egg Freezing 2EMD Serono Launches Landmark Patient Registry for Egg Freezing 3EMD Serono Launches Landmark Patient Registry for Egg Freezing 4
Mouse Anti-ROCK-1 (cleaved) Monoclonal Antibody, Unconjugated from BioVision
Mouse Anti-Plastin L Monoclonal Antibody, Unconjugated, Clone LPL4A.1 from Abcam
Mouse Anti-Chloramphenicol Acetyltransferase Monoclonal Antibody, Unconjugated, Clone CAT-1 from Abcam
... Cells are designed for use with the ProQuest Two-...203 contains deletions in the endogenous GAL4 and ...tems. The strain also has leu2 and trp1 mutations ...aV203 contains three GAL4 inducible reporter genes...
Biology Products: